Metabolic
Semaglutide
GLP-1 receptor agonist reference standard used in incretin-signalling and metabolic research models.
Indexed literature
Original citations from PubMed and ClinicalTrials.gov matched to Semaglutide. Indexing is not a quality endorsement; registration is not a published result.
- PubMedResearch publicationPharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study.
The Libyan journal of medicine · 2026 Dec 31
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- ClinicalTrials.govRegistered trial — no results postedA Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Updated 2026-10-19 · RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
- ClinicalTrials.govRegistered trial — no results postedSemaglutide for the Treatment of Cannabis Use Disorder
Updated 2026-10-19 · NOT YET RECRUITING PHASE2
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
- ClinicalTrials.govRegistered trial — no results postedSemaglutide Health Outcomes and Patient Adherence in Australia
Updated 2026-10-19 · NOT YET RECRUITING
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
- PubMedResearch publicationGLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study.
International journal of cardiology · 2026 Oct 17
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedResearch publicationEconomic evaluation of tirzepatide, semaglutide, and liraglutide in the treatment of obese and overweight patients without diabetes: a short-term cost-effectiveness analysis in Iran.
Journal of diabetes and metabolic disorders · 2026 Dec
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedReviewObesity: oral therapy for those afraid of needles.
Expert opinion on pharmacotherapy · 2026 Oct 16
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedResearch publicationGlucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity.
Journal of the American Heart Association · 2026 Oct 16
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedResearch publicationQualitative Exit Interviews to Characterize the Positive Treatment Experiences of Patients in the Phase III Trial of Orforglipron Versus Oral Semaglutide for the Treatment of Type 2 Diabetes.
The patient · 2026 Oct 16
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- ClinicalTrials.govRegistered trial — no results postedGLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
Updated 2026-10-16 · WITHDRAWN
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
- PubMedResearch publicationChanges in Gait Speed During a 12-Month Multidisciplinary Obesity Management Program Including Semaglutide: A Real-World Observational Study in Japanese Adults With Musculoskeletal Disorders.
Internal medicine (Tokyo, Japan) · 2026 Oct 15
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedReviewAdvances in disease management and treatment outcomes for obesity and knee osteoarthritis in primary care practice.
Current medical research and opinion · 2026 Oct 15
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedResearch publicationA Retrospective Chart Review of Tirzepatide and Semaglutide Use in Prediabetes Management and Cardiometabolic Outcomes in a Rural Primary Care Setting.
Journal of doctoral nursing practice · 2026 Oct 15
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedResearch publicationGLP-1 receptor agonists in Alzheimer's disease and MCI: a meta-analysis.
Alzheimer's & dementia (New York, N. Y.) · 2026 Oct-Dec
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- ClinicalTrials.govRegistered trial — no results postedA Study of BGM0504 in Participants With Type 2 Diabetes
Updated 2026-10-15 · ACTIVE NOT RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
- ClinicalTrials.govRegistered trial — no results postedA Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Updated 2026-10-15 · RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
- PubMedResearch publicationGLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps.
Journal of dental research · 2026 Oct 14
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedReviewGLP-1 receptor agonists and hair loss: adverse effect, epiphenomenon, or therapeutic paradox?
Acta diabetologica · 2026 Oct 14
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedReviewEmerging therapies for knee osteoarthritis.
Nature reviews. Rheumatology · 2026 Oct 14
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- PubMedResearch publicationReal-World Treatment Patterns and Weight Outcomes Before and After a Tirzepatide Price Increase in Over One Million Self-Paying UK Adults With Overweight or Obesity.
Diabetes, obesity & metabolism · 2026 Oct 14
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
- ClinicalTrials.govRegistered trial — no results postedSemaglutide vs Sitagliptin
Updated 2026-10-14 · ACTIVE NOT RECRUITING PHASE4
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
- ClinicalTrials.govRegistered trial — no results postedResearch Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Updated 2026-10-13 · ACTIVE NOT RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
- ClinicalTrials.govRegistered trial — no results postedReal-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes
Updated 2026-10-13 · COMPLETED
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
- ClinicalTrials.govRegistered trial — no results postedA Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based Pharmacotherapy for Weight Management Across the Binge Eating Spectrum
Updated 2026-10-13 · RECRUITING PHASE4
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
Materials supplied by Basic Tides are for in-vitro laboratory research only. This page contains no protocols, no dosing information and no therapeutic framing; third-party literature is indexed for reference and is not authored, endorsed or interpreted by Basic Tides.